Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
f-star
Biotech
F-star breaks free from invoX after $161M acquisition
The antibody-focused biotech is breaking free from invoX Pharma, a U.K.-based subsidiary of Sino Biopharmaceutical.
Gabrielle Masson
Apr 4, 2025 10:03am
Takeda adds F-Star collab to constellation worth up to $1B
Jul 5, 2023 2:00pm
Takeda weaves F-star tech into patchwork of cancer capabilities
Jul 20, 2022 9:55am
Merck takes 4th option on Big Pharma darling F-star's bispecific
Jan 5, 2022 10:20am
J&J ships another bispecific off to FDA in multiple myeloma
Dec 30, 2021 9:52am
F-Star's J&J deal is largest yet with $1.35B in biobucks
Oct 20, 2021 10:18am
